Boehringer In­gel­heim nabs new US pres­i­dent and CEO; As­traZeneca vet hops aboard No­vavax as CMO

Jean-Michel Boers, who joined Boehringer In­gel­heim in 1998, is step­ping in as US pres­i­dent and CEO. He suc­ceeds Wolf­gang Baik­er, who is re­tir­ing af­ter 31 years with the com­pa­ny. Af­ter start­ing out at Boehringer In­gel­heim 22 years ago in Bel­gium as head of busi­ness in­for­ma­tion and sup­port, Boers has steadi­ly worked his way up the lad­der in more promi­nent lead­er­ship roles. He has led the US hu­man phar­ma busi­ness at the Ger­man drug­mak­er since Jan­u­ary 2017.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.